Concepedia

Publication | Open Access

A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis

129

Citations

19

References

2016

Year

Abstract

This study provides Class I evidence that for patients with generalized MG MTX does not significantly reduce the prednisone AUDTC over 12 months of therapy.

References

YearCitations

Page 1